Discount Agreement for Clobazam (TAB) by DAK-Gesundheit
DAK-Gesundheit is seeking partners for a non-exclusive discount agreement for Clobazam (TAB) from 01.06.2026 to 31.05.2028, with an extension option. This allows all pharmaceutical companies to join under attractive conditions.
CONTRACTING AUTHORITY
Name
DAK-Gesundheit
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
1051 days remaining(LOT-0001)
Published